Melanoma (stage III or IV) - ipilimumab: revised addendum by Liverpool reviews and implementation group (LRiG)
Melanoma (stage III or IV) - ipilimumab: revised addendum by Liverpool reviews and implementation group (LRiG)
02 November 2012 (504.48 Kb 26 sec) |
This page was last updated: 31 October 2012